First New York Securities’s Imperva, Inc. IMPV Stock Holding History

First New York Securities’s Portfolio IMPV Stock Details IMPV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-14,000	Closed	-$752K	–	235
2016 Q3	$752K	Buy	+14,000	New	+$650K	0.5%	39
2015 Q1	–	Sell	-500	Closed	-$24.7K	–	498
2014 Q4	$24.7K	Sell	500 -2,400	-83%	-$96.1K	0.04%	186
2014 Q3	$83.3K	Buy	+2,900	New	+$78.7K	0.06%	196

Other funds holding IMPV

Elliott Management New York $11.8B AUM 20.29% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Eminence Capital New York $4.36B AUM 3.1% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

PCM

Penserra Capital Management Orinda, California $13B AUM 71.84% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Litespeed Management New York $48.2M AUM 9.81% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

First New York Securities's IMPV Position: Q4 2016 in Review

First New York Securities sold out of Imperva, Inc. (IMPV) in Q4 2016, closing a stake of 14,000 shares — an estimated $752K sold.

First New York Securities first reported a position in IMPV in Q3 2014 and held it in 3 quarters. The position peaked at $752K in Q3 2016. 172 funds tracked by Wall St. Rank hold IMPV as of Q4 2016.

First New York Securities reported no remaining Imperva, Inc. position as of Q4 2016 after selling out during the quarter.
First New York Securities sold 14,000 Imperva, Inc. shares in Q4 2016, an estimated $752K.
First New York Securities first reported a position in Imperva, Inc. in Q3 2014 and held it in 3 quarters.
First New York Securities's Imperva, Inc. position peaked at $752K in Q3 2016.
172 funds tracked by Wall St. Rank held Imperva, Inc. as of Q4 2016.

Based on First New York Securities's 13F filing for Q4 2016, filed 7 Feb 2017.